 | • レポートコード：D0GIR-05886 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、腎臓病治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。腎臓病治療薬の種類別市場規模（錠剤、カプセル、その他）、用途別市場規模（慢性糸球体腎炎、ネフローゼ症候群、慢性腎不全、腎結石、腎嚢胞（多発性嚢胞腎）、糖尿病性腎症、高血圧性腎症、紫斑病性腎炎、ループス腎炎、小児腎疾患）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、AbbVie、Pfizer、Sanofi、Kissei Pharmaceutical、Roche、Teva Pharmaceutical Industries、Keryx Biopharmaceuticals、AstraZeneca、Amgen、Changxing Pharmaceutical、Tianjin Tongrentang Group、zhejiang Shengbokang Pharmaceutical、Hebei Ruisen Pharmaceutical、Jiangxi Jimin Kexin Jinshuibao Pharmaceutical、Datong Liqun Pharmaceutical ・地域別グローバル市場分析 2015年-2020年 ・腎臓病治療薬の北米市場（アメリカ、カナダ、メキシコ） ・腎臓病治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・腎臓病治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・腎臓病治療薬の南米市場（ブラジル、アルゼンチン） ・腎臓病治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：錠剤、カプセル、その他 ・用途別分析：慢性糸球体腎炎、ネフローゼ症候群、慢性腎不全、腎結石、腎嚢胞（多発性嚢胞腎）、糖尿病性腎症、高血圧性腎症、紫斑病性腎炎、ループス腎炎、小児腎疾患 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Kidney Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Kidney Disease Drugs sales will be xx in 2020 from Kidney Disease Drugs million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Kidney Disease Drugs market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Kidney Disease Drugs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Kidney Disease Drugs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Kidney Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Kidney Disease Drugs market has been segmented into
Tablets
Capsule
Other
By Application, Kidney Disease Drugs has been segmented into:
Chronic Glomerulonephritis
Nephrotic Syndrome
Chronic Renal Failure
Kidney Stones
Renal Cyst (polycystic Kidney)
Diabetic Nephropathy
Hypertensive Nephropathy
Purpura Nephritis
Lupus Nephritis
Pediatric Kidney Disease
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Kidney Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Kidney Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Kidney Disease Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Kidney Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Kidney Disease Drugs Market Share Analysis
Kidney Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Kidney Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Kidney Disease Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Kidney Disease Drugs are:
GlaxoSmithKline
AbbVie
Pfizer
Sanofi
Kissei Pharmaceutical
Roche
Teva Pharmaceutical Industries
Keryx Biopharmaceuticals
AstraZeneca
Amgen
Changxing Pharmaceutical
Tianjin Tongrentang Group
zhejiang Shengbokang Pharmaceutical
Hebei Ruisen Pharmaceutical
Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
Datong Liqun Pharmaceutical
Among other players domestic and global, Kidney Disease Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Kidney Disease Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Kidney Disease Drugs, with price, sales, revenue and global market share of Kidney Disease Drugs in 2018 and 2019.
Chapter 3, the Kidney Disease Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Kidney Disease Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Kidney Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Kidney Disease Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Kidney Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Kidney Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Kidney Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Chronic Glomerulonephritis
1.3.3 Nephrotic Syndrome
1.3.4 Chronic Renal Failure
1.3.5 Kidney Stones
1.3.6 Renal Cyst (polycystic Kidney)
1.3.7 Diabetic Nephropathy
1.3.8 Hypertensive Nephropathy
1.3.9 Purpura Nephritis
1.3.10 Lupus Nephritis
1.3.11 Pediatric Kidney Disease
1.4 Overview of Global Kidney Disease Drugs Market
1.4.1 Global Kidney Disease Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Kidney Disease Drugs Industry Impact
1.6.1 COVID-19 Potential Implications for the Kidney Disease Drugs
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Kidney Disease Drugs
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AbbVie SWOT Analysis
2.2.4 AbbVie Product and Services
2.2.5 AbbVie Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kissei Pharmaceutical
2.5.1 Kissei Pharmaceutical Details
2.5.2 Kissei Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kissei Pharmaceutical SWOT Analysis
2.5.4 Kissei Pharmaceutical Product and Services
2.5.5 Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Teva Pharmaceutical Industries
2.7.1 Teva Pharmaceutical Industries Details
2.7.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Teva Pharmaceutical Industries SWOT Analysis
2.7.4 Teva Pharmaceutical Industries Product and Services
2.7.5 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Keryx Biopharmaceuticals
2.8.1 Keryx Biopharmaceuticals Details
2.8.2 Keryx Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Keryx Biopharmaceuticals SWOT Analysis
2.8.4 Keryx Biopharmaceuticals Product and Services
2.8.5 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AstraZeneca SWOT Analysis
2.9.4 AstraZeneca Product and Services
2.9.5 AstraZeneca Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amgen
2.10.1 Amgen Details
2.10.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amgen SWOT Analysis
2.10.4 Amgen Product and Services
2.10.5 Amgen Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Changxing Pharmaceutical
2.11.1 Changxing Pharmaceutical Details
2.11.2 Changxing Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Changxing Pharmaceutical SWOT Analysis
2.11.4 Changxing Pharmaceutical Product and Services
2.11.5 Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Tianjin Tongrentang Group
2.12.1 Tianjin Tongrentang Group Details
2.12.2 Tianjin Tongrentang Group Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Tianjin Tongrentang Group SWOT Analysis
2.12.4 Tianjin Tongrentang Group Product and Services
2.12.5 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 zhejiang Shengbokang Pharmaceutical
2.13.1 zhejiang Shengbokang Pharmaceutical Details
2.13.2 zhejiang Shengbokang Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 zhejiang Shengbokang Pharmaceutical SWOT Analysis
2.13.4 zhejiang Shengbokang Pharmaceutical Product and Services
2.13.5 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Hebei Ruisen Pharmaceutical
2.14.1 Hebei Ruisen Pharmaceutical Details
2.14.2 Hebei Ruisen Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Hebei Ruisen Pharmaceutical SWOT Analysis
2.14.4 Hebei Ruisen Pharmaceutical Product and Services
2.14.5 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical
2.15.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Details
2.15.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical SWOT Analysis
2.15.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Product and Services
2.15.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Datong Liqun Pharmaceutical
2.16.1 Datong Liqun Pharmaceutical Details
2.16.2 Datong Liqun Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Datong Liqun Pharmaceutical SWOT Analysis
2.16.4 Datong Liqun Pharmaceutical Product and Services
2.16.5 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Kidney Disease Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Kidney Disease Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Kidney Disease Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Kidney Disease Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Kidney Disease Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Kidney Disease Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Kidney Disease Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Kidney Disease Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Kidney Disease Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Kidney Disease Drugs Sales and Growth Rate (2015-2020)
4.5 South America Kidney Disease Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Kidney Disease Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Kidney Disease Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Kidney Disease Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Kidney Disease Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Kidney Disease Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Kidney Disease Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Kidney Disease Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Kidney Disease Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Kidney Disease Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Kidney Disease Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Kidney Disease Drugs Sales and Growth Rate (2015-2020)
6.3 UK Kidney Disease Drugs Sales and Growth Rate (2015-2020)
6.4 France Kidney Disease Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Kidney Disease Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Kidney Disease Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Kidney Disease Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Kidney Disease Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7.5 India Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Kidney Disease Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Kidney Disease Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Kidney Disease Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Kidney Disease Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Kidney Disease Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Kidney Disease Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Kidney Disease Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Kidney Disease Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Kidney Disease Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Kidney Disease Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Kidney Disease Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Kidney Disease Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Kidney Disease Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Kidney Disease Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Kidney Disease Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Kidney Disease Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Kidney Disease Drugs Price by Type (2015-2020)
11 Global Kidney Disease Drugs Market Segment by Application
11.1 Global Kidney Disease Drugs Sales Market Share by Application (2015-2020)
11.2 Global Kidney Disease Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Kidney Disease Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Kidney Disease Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Kidney Disease Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Kidney Disease Drugs Market Forecast (2021-2025)
12.2.2 Europe Kidney Disease Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Kidney Disease Drugs Market Forecast (2021-2025)
12.2.4 South America Kidney Disease Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Kidney Disease Drugs Market Forecast (2021-2025)
12.3 Kidney Disease Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Kidney Disease Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Kidney Disease Drugs Market Share Forecast by Type (2021-2025)
12.4 Kidney Disease Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Kidney Disease Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Kidney Disease Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Kidney Disease Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Kidney Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Kidney Disease Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Kidney Disease Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Kidney Disease Drugs Major Business
Table 10. GlaxoSmithKline Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 11. GlaxoSmithKline SWOT Analysis
Table 12. GlaxoSmithKline Kidney Disease Drugs Product and Services
Table 13. GlaxoSmithKline Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. AbbVie Basic Information, Manufacturing Base and Competitors
Table 15. AbbVie Kidney Disease Drugs Major Business
Table 16. AbbVie Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 17. AbbVie SWOT Analysis
Table 18. AbbVie Kidney Disease Drugs Product and Services
Table 19. AbbVie Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Pfizer Basic Information, Manufacturing Base and Competitors
Table 21. Pfizer Kidney Disease Drugs Major Business
Table 22. Pfizer Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Pfizer SWOT Analysis
Table 24. Pfizer Kidney Disease Drugs Product and Services
Table 25. Pfizer Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Sanofi Basic Information, Manufacturing Base and Competitors
Table 27. Sanofi Kidney Disease Drugs Major Business
Table 28. Sanofi Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Sanofi SWOT Analysis
Table 30. Sanofi Kidney Disease Drugs Product and Services
Table 31. Sanofi Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Kissei Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 33. Kissei Pharmaceutical Kidney Disease Drugs Major Business
Table 34. Kissei Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Kissei Pharmaceutical SWOT Analysis
Table 36. Kissei Pharmaceutical Kidney Disease Drugs Product and Services
Table 37. Kissei Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Kidney Disease Drugs Major Business
Table 40. Roche Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 41. Roche SWOT Analysis
Table 42. Roche Kidney Disease Drugs Product and Services
Table 43. Roche Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 45. Teva Pharmaceutical Industries Kidney Disease Drugs Major Business
Table 46. Teva Pharmaceutical Industries Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Teva Pharmaceutical Industries SWOT Analysis
Table 48. Teva Pharmaceutical Industries Kidney Disease Drugs Product and Services
Table 49. Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Keryx Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 51. Keryx Biopharmaceuticals Kidney Disease Drugs Major Business
Table 52. Keryx Biopharmaceuticals Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Keryx Biopharmaceuticals SWOT Analysis
Table 54. Keryx Biopharmaceuticals Kidney Disease Drugs Product and Services
Table 55. Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 57. AstraZeneca Kidney Disease Drugs Major Business
Table 58. AstraZeneca Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 59. AstraZeneca SWOT Analysis
Table 60. AstraZeneca Kidney Disease Drugs Product and Services
Table 61. AstraZeneca Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Amgen Basic Information, Manufacturing Base and Competitors
Table 63. Amgen Kidney Disease Drugs Major Business
Table 64. Amgen Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Amgen SWOT Analysis
Table 66. Amgen Kidney Disease Drugs Product and Services
Table 67. Amgen Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Changxing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Changxing Pharmaceutical Kidney Disease Drugs Major Business
Table 70. Changxing Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 71. Changxing Pharmaceutical SWOT Analysis
Table 72. Changxing Pharmaceutical Kidney Disease Drugs Product and Services
Table 73. Changxing Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Tianjin Tongrentang Group Basic Information, Manufacturing Base and Competitors
Table 75. Tianjin Tongrentang Group Kidney Disease Drugs Major Business
Table 76. Tianjin Tongrentang Group Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 77. Tianjin Tongrentang Group SWOT Analysis
Table 78. Tianjin Tongrentang Group Kidney Disease Drugs Product and Services
Table 79. Tianjin Tongrentang Group Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. zhejiang Shengbokang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Major Business
Table 82. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 83. zhejiang Shengbokang Pharmaceutical SWOT Analysis
Table 84. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product and Services
Table 85. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Hebei Ruisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Major Business
Table 88. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 89. Hebei Ruisen Pharmaceutical SWOT Analysis
Table 90. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product and Services
Table 91. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 92. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 93. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Major Business
Table 94. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 95. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical SWOT Analysis
Table 96. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product and Services
Table 97. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 98. Datong Liqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Datong Liqun Pharmaceutical Kidney Disease Drugs Major Business
Table 100. Datong Liqun Pharmaceutical Kidney Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 101. Datong Liqun Pharmaceutical SWOT Analysis
Table 102. Datong Liqun Pharmaceutical Kidney Disease Drugs Product and Services
Table 103. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 104. Global Kidney Disease Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 105. Global Kidney Disease Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 106. Global Kidney Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 107. Global Kidney Disease Drugs Sales Market Share by Regions (2015-2020)
Table 108. Global Kidney Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 109. North America Kidney Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 110. North America Kidney Disease Drugs Sales Market Share by Countries (2015-2020)
Table 111. North America Kidney Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 112. North America Kidney Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 113. Europe Kidney Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 114. Europe Kidney Disease Drugs Sales Market Share by Countries (2015-2020)
Table 115. Europe Kidney Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 116. Asia-Pacific Kidney Disease Drugs Sales by Regions (2015-2020) (K Units)
Table 117. Asia-Pacific Kidney Disease Drugs Sales Market Share by Regions (2015-2020)
Table 118. Asia-Pacific Kidney Disease Drugs Revenue by Regions (2015-2020) (USD Million)
Table 119. South America Kidney Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 120. South America Kidney Disease Drugs Sales Market Share by Countries (2015-2020)
Table 121. South America Kidney Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 122. South America Kidney Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 123. Middle East & Africa Kidney Disease Drugs Sales by Countries (2015-2020) (K Units)
Table 124. Middle East & Africa Kidney Disease Drugs Sales Market Share by Countries (2015-2020)
Table 125. Middle East & Africa Kidney Disease Drugs Revenue by Countries (2015-2020) (USD Million)
Table 126. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 127. Global Kidney Disease Drugs Sales by Type (2015-2020) (K Units)
Table 128. Global Kidney Disease Drugs Sales Share by Type (2015-2020)
Table 129. Global Kidney Disease Drugs Revenue by Type (2015-2020) (USD Million)
Table 130. Global Kidney Disease Drugs Revenue Share by Type (2015-2020)
Table 131. Global Kidney Disease Drugs Sales by Application (2015-2020) (K Units)
Table 132. Global Kidney Disease Drugs Sales Share by Application (2015-2020)
Table 133. Global Kidney Disease Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 134. Global Kidney Disease Drugs Market Share Forecast by Regions (2021-2025)
Table 135. Global Kidney Disease Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 136. Global Kidney Disease Drugs Market Share Forecast by Type (2021-2025)
Table 137. Global Kidney Disease Drugs Sales Forecast by Application (2021-2025)
Table 138. Global Kidney Disease Drugs Market Share Forecast by Application (2021-2025)
Table 139. Direct Channel Pros & Cons
Table 140. Indirect Channel Pros & Cons
Table 141. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Kidney Disease Drugs Picture
Figure 2. Global Sales Market Share of Kidney Disease Drugs by Type in 2019
Figure 3. Tablets Picture
Figure 4. Capsule Picture
Figure 5. Other Picture
Figure 6. Kidney Disease Drugs Sales Market Share by Application in 2018
Figure 7. Chronic Glomerulonephritis Picture
Figure 8. Nephrotic Syndrome Picture
Figure 9. Chronic Renal Failure Picture
Figure 10. Kidney Stones Picture
Figure 11. Renal Cyst (polycystic Kidney) Picture
Figure 12. Diabetic Nephropathy Picture
Figure 13. Hypertensive Nephropathy Picture
Figure 14. Purpura Nephritis Picture
Figure 15. Lupus Nephritis Picture
Figure 16. Global Kidney Disease Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 17. United States Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Canada Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Mexico Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Germany Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. France Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. UK Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Russia Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Italy Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. China Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Japan Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Korea Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. India Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Southeast Asia Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Australia Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 31. Brazil Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Egypt Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Saudi Arabia Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 34. South Africa Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Turkey Kidney Disease Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 36. Global Kidney Disease Drugs Sales Market Share by Manufacturer in 2019
Figure 37. Global Kidney Disease Drugs Revenue Market Share by Manufacturer in 2019
Figure 38. Top 3 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 39. Top 6 Kidney Disease Drugs Manufacturer (Revenue) Market Share in 2019
Figure 40. Key Manufacturer Market Share Trend
Figure 41. Global Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 42. Global Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. Global Kidney Disease Drugs Revenue Market Share by Regions (2015-2020)
Figure 44. Global Kidney Disease Drugs Revenue Market Share by Regions in 2018
Figure 45. North America Kidney Disease Drugs Sales and Growth Rate (2015-2020)
Figure 46. Europe Kidney Disease Drugs Sales and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Kidney Disease Drugs Sales and Growth Rate (2015-2020)
Figure 48. South America Kidney Disease Drugs Sales and Growth Rate (2015-2020)
Figure 49. Middle East & Africa Kidney Disease Drugs Sales and Growth Rate (2015-2020)
Figure 50. North America Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. North America Kidney Disease Drugs Sales Market Share by Countries (2015-2020)
Figure 52. North America Kidney Disease Drugs Sales Market Share by Countries in 2018
Figure 53. North America Kidney Disease Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 54. North America Kidney Disease Drugs Revenue Market Share by Countries in 2018
Figure 55. United States Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Canada Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Mexico Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Europe Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Europe Kidney Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 60. Europe Kidney Disease Drugs Revenue Market Share by Countries in 2019
Figure 61. Germany Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. UK Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. France Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Russia Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Italy Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Asia-Pacific Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. Asia-Pacific Kidney Disease Drugs Sales Market Share by Regions 2019
Figure 68. Asia-Pacific Kidney Disease Drugs Revenue Market Share by Regions 2019
Figure 69. China Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Japan Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Korea Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 72. India Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Southeast Asia Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. South America Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. South America Kidney Disease Drugs Sales Market Share by Countries in 2019
Figure 76. South America Kidney Disease Drugs Revenue Market Share by Countries in 2019
Figure 77. Brazil Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Argentina Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Middle East and Africa Kidney Disease Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 80. Middle East and Africa Kidney Disease Drugs Sales Market Share by Countries in 2019
Figure 81. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 82. Middle East and Africa Kidney Disease Drugs Revenue Market Share by Countries in 2019
Figure 83. Saudi Arabia Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Egypt Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 85. Turkey Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 86. South Africa Kidney Disease Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 87. Global Kidney Disease Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 88. Global Kidney Disease Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 89. North America Sales Kidney Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Europe Sales Kidney Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Asia-Pacific Sales Kidney Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 92. South America Sales Kidney Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 93. Middle East & Africa Sales Kidney Disease Drugs Market Forecast (2021-2025) (K Units)
Figure 94. Sales Channel: Direct Channel vs Indirect Channel
末期腎臓病の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The End-Stage Kidney Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 腎臓がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Kidney Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidney Cancer market report pro…
- 慢性心不全（CHF）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chronic Heart Failure (CHF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- メニエール病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Meniere's Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere's Disease Dru…
- セリアック病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Celiac Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Celiac Disease Drugs mar…